Several DHPPIQ derivatives showed high inhibitory potency toward P-gp, attaining sub-micromolar 50% inhibition of the cell population growth (IC50) values, and the ability to reverse in vitro P-gp-mediated resistance in doxorubicin-resistant tumor cells [4]. This evidence concerns the gene PGP and neoplasm.